Empiric Antibiotic Therapy for Infective Endocarditis

1. First‑line Regimens for Native Valve Endocarditis

• Ampicillin 12 g/day IV (divided 4–6 doses) + (Flu)cloxacillin or oxacillin 12 g/day IV (divided 4–6 doses) + Gentamicin 3 mg/kg/day IV or IM (single daily dose) – designed to cover staphylococci, streptococci and enterococci. The European Society of Cardiology (ESC) classifies this regimen as Class IIa, Level C. 1

• For patients with penicillin allergy: Vancomycin 30–60 mg/kg/day IV (divided 2–3 doses) + Gentamicin 3 mg/kg/day IV or IM (single daily dose) – ESC recommendation Class IIb, Level C. 1

2. Prosthetic Valve Endocarditis

• Early prosthetic valve infection (< 12 months post‑surgery): Vancomycin 30 mg/kg/day IV (divided 2 doses) + Gentamicin 3 mg/kg/day IV/IM (single dose) + Rifampin 900–1200 mg/day IV or oral (divided 2–3 doses). Rifampin should be added 3–5 days after vancomycin and gentamicin are started. This combination targets methicillin‑resistant Staphylococcus spp., enterococci and non‑HACEK gram‑negative pathogens. ESC recommendation (Class IIa, Level C). 1

• Late prosthetic valve infection (≥ 12 months): Use the same regimen as native valve endocarditis (ampicillin + (flu)cloxacillin/oxacillin + gentamicin). ESC recommendation (Class IIa, Level C). 1

3. Diagnostic Timing and Immediate Therapy

• In critically ill patients, obtain three sets of blood cultures from separate venipuncture sites at 30‑minute intervals, then start empiric antibiotics immediately after cultures are drawn. ESC guidance. 1

4. Management of Culture‑Negative Endocarditis

• Consult an infectious‑disease specialist for all culture‑negative cases. ESC recommendation. 2

• If there is no clinical response, broaden antimicrobial coverage by adding doxycycline or a quinolone. ESC recommendation. [1][2]

5. Pathogen‑Specific Regimens

HACEK Organisms

• Ceftriaxone 2 g/day IV – 4 weeks for native valve infection, 6 weeks for prosthetic valve infection. ESC recommendation. 2

• Alternative: Ampicillin 12 g/day IV (divided 4–6 doses) + Gentamicin 3 mg/kg/day for 4–6 weeks. ESC recommendation. 2

Non‑HACEK Gram‑Negative Bacteria

• Beta‑lactam + aminoglycoside for ≥ 6 weeks; add a quinolone or trimethoprim‑sulfamethoxazole based on susceptibility. ESC recommendation to discuss with an endocarditis team or infectious‑disease specialist. 2

Fungal Endocarditis

• Combined antifungal therapy plus surgical valve replacement is required; mortality exceeds 50 %. ESC recommendation. 2

6. Therapeutic Drug Monitoring

• Gentamicin and vancomycin require weekly serum drug‑level measurements and renal‑function testing; dosing adjustments should follow the tables provided in ESC guidelines. ESC recommendation. 1

7. Assessment of Treatment Response

• Repeat blood cultures until sterility is achieved; the causative pathogen is usually identified within the first 48 hours, allowing therapy to be tailored to susceptibility patterns. ESC recommendation. 1

8. Health‑Care‑Associated Native Valve Endocarditis

• In settings where MRSA prevalence > 5 %, initiate cloxacillin + vancomycin until Staphylococcus aureus is identified. ESC recommendation. 1

9. Factors Guiding Empiric Regimen Choice

• Prior antibiotic exposure,
• Valve type (native vs prosthetic) and timing of surgery,
• Infection source (community‑acquired, hospital‑acquired, health‑care‑associated),
• Local epidemiology and resistance patterns.

Empirical Antibiotic Treatment for Infective Endocarditis

Introduction to Empirical Treatment

• The European Society of Cardiology recommends ampicillin plus (flu)cloxacillin/oxacillin plus gentamicin for community-acquired native valve endocarditis, and vancomycin plus gentamicin plus rifampin for prosthetic valve endocarditis 3, 4

Empirical Treatment Algorithm

• For community-acquired native valve endocarditis, the first-line regimen includes ampicillin: 12 g/day IV in 4-6 doses, plus gentamicin: 3 mg/kg/day IV or IM in 1 dose 3, 4, 5
• For penicillin-allergic patients with community-acquired native valve endocarditis, vancomycin: 30-60 mg/kg/day IV in 2-3 doses, plus gentamicin: 3 mg/kg/day IV or IM in 1 dose 3, 4, 5
• For early prosthetic valve endocarditis or healthcare-associated endocarditis, the standard regimen includes vancomycin: 30 mg/kg/day IV in 2 doses, plus gentamicin: 3 mg/kg/day IV or IM in 1 dose, plus rifampin: 900-1200 mg IV or orally in 2-3 divided doses 3, 4

Special Considerations

• For blood culture-negative infective endocarditis, consultation with an infectious disease specialist is strongly recommended, and consideration of extending antibiotic spectrum to cover BCNIE pathogens, such as adding doxycycline or quinolones to the regimen 3, 4, 6
• For HACEK organisms, the recommended treatment is ceftriaxone: 2 g/day IV for 4 weeks in native valve IE and 6 weeks in prosthetic valve IE, or alternative ampicillin (12 g/day IV in 4-6 doses) plus gentamicin (3 mg/kg/day) for 4-6 weeks 5, 6
• For non-HACEK gram-negative bacteria, combination of beta-lactams and aminoglycosides for at least 6 weeks, with consideration of additional quinolones or cotrimoxazole based on susceptibility 6, 7
• For fungal endocarditis, combined antifungal therapy plus surgical valve replacement is typically required, with high mortality (>50%) despite aggressive treatment 6, 7

Important Clinical Pearls

• Always obtain three sets of blood cultures at 30-minute intervals before initiating antibiotics, and empirical therapy should be started promptly after blood cultures are drawn in acutely ill patients 4, 6
• The choice of empirical antibiotics should consider prior antibiotic exposure, type of valve, time since valve surgery, setting of infection, and local epidemiology and resistance patterns 3, 4, 6
• Monitoring recommendations include regular clinical assessment and follow-up blood cultures, monitoring renal function when using aminoglycosides, and therapeutic drug monitoring for vancomycin and gentamicin 5